반응식
CN(C)CCC[N:6]1[CH2:11][CH2:10][N:9]([N:12]2[NH:16][CH:15]=[C:14]([C:17]3[N:18]([CH3:25])[C:19]([N+:22]([O-:24])=[O:23])=[CH:20][N:21]=3)[S:13]2)[CH2:8][CH2:7]1.[S:27]1[CH:31]=[CH:30][N:29]=[C:28]1N1CCNCC1.CN(C)CCCN1CCNCC1>>[S:27]1[CH:31]=[CH:30][N:29]=[C:28]1[N:6]1[CH2:11][CH2:10][N:9]([N:12]2[NH:16][CH:15]=[C:14]([C:17]3[N:18]([CH3:25])[C:19]([N+:22]([O-:24])=[O:23])=[CH:20][N:21]=3)[S:13]2)[CH2:8][CH2:7]1참가 물질
4
실험 절차
The preparation of the subject compound is carried out essentially as described for the 2-[4-(3-dimethylaminopropyl)-1-piperazinyl] derivative (Example 35), an equivalent of 1-(2-thiazolyl)piperazine replacing the 1-(3-dimethylaminopropyl)piperazine. After recrystallization from 2-methoxyethanol, the pure compound melts at 297°-300° C.
후처리
- customThe preparation of the subject compound
- customAfter recrystallization from 2-methoxyethanol
출처 및 근거
- ORD 기록
- ord-10dfc038fa9d47f89d1562cb38168a32
- 출처 데이터셋
- uspto-grants-1977_12
- 특허 번호
- US04065567
연결된 노트
불러오는 중…